Investing Ideas
/
Swiss Pharmaceuticals & Biotech Sustainable Track Record

Swiss Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	BSLN New Basilea Pharmaceutica	CHF 45.60	13.6%	26.0%	CHF 553.1m	CHF 76.92	PE7.1x	E6.5%	0%

Page 1 of 1